Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients with Inflammatory Bowel Disease.

Gastroenterology. 2020 May 29;:

Authors: Lukin DJ, Kumar A, Hajifathalian K, Sharaiha RZ, Scherl EJ, Longman RS, JRC Study Group, WCM-GI Study Group

PMID: 32479824 [PubMed – as supplied by publisher]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/32479824?dopt=Abstract